BeStock  
Stocks › Biotechnology › DMRA

Damora Therapeutics DMRA

US equityMarket cap rank #2901Biotechnology
$23.22 −$1.08 (-4.44%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $23.22 0.00%
Open$23.81
Prev close$24.30
Day range$23.13 – $24.51
Volume643.4K
Market cap$1.44B
P/E (TTM)13.6
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings12.6x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -7.0x

#940 of 2990 stocks by PE (1 = cheapest)

Price / book3.7x
CheapRich

Near the top of its 5-year range · 90th percentile, 5-year average 2.4x

#4022 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-131x-78x-25x29xOct '21Jul '23Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$36.51
Price vs. fair value-36.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.66 – 2.42 90% (pricier than usual) #4022 of 5329 (1 = cheapest)
PE 12.63 -9.52 -6.97 99% (pricier than usual) #940 of 2990 (1 = cheapest)
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DMRA.

Sign in to join the discussion.

Scroll to Top